3Pridjian G, Puschett JB. Preeclampsia. Part 1: Clinical and pathophysiologic considerations. Obstet Gynecol Surv,2002,57:598-618.
4Magann EF, Martin JN Jr. Complicated postpartum preeclampsia-eclampsia. Obstet Gynecol Clin North Am,1995,22:337-356.
5Harms K, Rath W, Herting E, et al. Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. Am J Perinatol, 1995, 12:1-6.
6Norwitz ER, Hsu CD, Repke JT. Acute complications of preeclampsia. Clin Obstet Gynecol, 2002, 45:308-329.
7Tompkins MJ,Thiagarajah S. HELLP syndrome:The benefit of corticosteroids. Am J Obstet Gynecol,1999,181:304-309.
8Martin JN Jr, Perry KG Jr, Blake PG, et al. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP syndrome. Am J Obstet Gynecol,1997,177:1011-1017.
9Bussen S, Sutterlin M, Steck T. Plasma endothelin and big endothelin level in women with severe preeclampsia or HELLP-syndrome.Arch Gynecol Obstet, 1999,262 (3-4): 113-119
10Ibdah J A, Yang Z, Bennett MJ. Liver disease in pregnancy and fetal acid oxidation defects. Mol Genet Metab, 2000,71 (1-2): 182-189
